Dr. Aderonke Obayomi, MD

Dr. Obayomi practices at Bislr Medical Groups Of Mount Sinai in New York, New York.

Dr. Obayomi's NPI, 1023578283, was assigned on March 23, 2019. Dr. Obayomi graduated from Tulane University School of Medicine in 2019. Dr. Obayomi holds New York license 321539.

Dr. Obayomi's primary practice is Bislr Medical Groups of Mount Sinai, at 200 W 57th St, New York, NY 10019. The practice phone is (212) 663-6604.

Dr. Obayomi's primary practice is Bislr Medical Groups Of Mount Sinai in New York, New York. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Obayomi to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Obayomi practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Obayomi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Obayomi is licensed in New York.

CMS data shows 383 Medicare services from Dr. Obayomi across 8 procedure codes in 2024, for 199 Medicare patients. Medicare paid $31,404 for them. Every service was in an office.

CMS counts 199 Medicare patients who saw Dr. Obayomi in 2024. The largest group is 65 to 74, with 92 patients. 70% of them have high cholesterol, and 58% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Obayomi's median patient age at 41, with 69% women.

In 2024, Dr. Obayomi wrote 476 Medicare Part D claims for 147 patients. 97% of them were for generic drugs. CMS names the drug for 382 of them, across 10 drugs with 11 or more claims each, at $9,245 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Obayomi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Obayomi as offering telehealth. CMS counts 90 procedures of removal of skin lesions by Dr. Obayomi, more than 75% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Obayomi, published from 2019 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Cicatrix and Hair. Dr. Obayomi's most frequent co-authors are Mark Correa, MD, Giuseppe Vittorio Ingrasci, MD and Michael Joseph Lauth, MD.

CMS Open Payments shows 242 general payments to Dr. Obayomi from 20 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 88% of the total. Abbvie Inc. paid the most, $2,614.

Dr. Obayomi graduated from Tulane University School of Medicine in 2019.